ETrade Capital Management’s Abiomed Inc ABMD Stock Holding History

ETrade Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$1.49M	Buy	+5,361	New	+$1.54M	0.03%	277
2019 Q4	–	Sell	-7,726	Closed	-$1.37M	–	847
2019 Q3	$1.37M	Buy	7,726 +3,226	+72%	+$697K	0.03%	272
2019 Q2	$1.17M	Buy	4,500 +740	+20%	+$196K	0.03%	312
2019 Q1	$1.07M	Buy	3,760 +934	+33%	+$310K	0.03%	315
2018 Q4	$919K	Buy	2,826 +723	+34%	+$251K	0.03%	324
2018 Q3	$946K	Sell	2,103 -39	-2%	-$15.4K	0.03%	381
2018 Q2	$876K	Buy	+2,142	New	+$776K	0.03%	393

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ETrade Capital Management's ABMD Position: Q3 2020 in Review

ETrade Capital Management opened a new position in Abiomed Inc (ABMD) in Q3 2020: 5,361 shares worth $1.49M. The stake represents 0.03% of the portfolio and ranks #277 among its holdings. This is a return to the name: ETrade Capital Management previously reported a position in ABMD as recently as Q3 2019.

ETrade Capital Management first reported a position in ABMD in Q2 2018 and has held it in 7 quarters since. 498 funds tracked by Wall St. Rank hold ABMD as of Q3 2020.

ETrade Capital Management held 5,361 shares of Abiomed Inc worth $1.49M as of Q3 2020.
Abiomed Inc was a new ETrade Capital Management position in Q3 2020.
Abiomed Inc made up 0.03% of ETrade Capital Management's portfolio in Q3 2020, its #277 holding.
ETrade Capital Management first reported a position in Abiomed Inc in Q2 2018 and has held it in 7 quarters since.
498 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2020.

Based on ETrade Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.